Skip to main content

Cannabis plants are seen during a tour of a Hexo Corp. production facility on Oct. 11, 2018, in Masson Angers, Que.

Adrian Wyld/The Canadian Press

Cannabis company Hexo Corp. is reducing its work force by 200 jobs to adjust for expected future revenues and “ensure the long-term viability” of the firm, its chief executive said.

The announcement comes two weeks after Hexo cut its net revenue forecast for the fourth quarter and withdrew its 2020 outlook, citing factors including slower-than-expected pot store rollouts and early signs of pricing pressure.

Hexo, based in Gatineau, Que., had 822 employees as of April 30, according to a filing from its third-quarter financial results. On May 24, it added an additional 250 employees through its acquisition of licensed producer Newstrike Brands Ltd.

Story continues below advertisement

Chief executive Sebastien St-Louis said this was his “hardest day” at the company.

“While it is extremely difficult to say goodbye to trusted colleagues, I am confident that we have made sound decisions to ensure the long-term viability of HEXO Corp.,” he said in a statement. “The actions taken this week are about rightsizing the organization to the revenue we expect to achieve in 2020.”

The cuts included the elimination of some executive positions and the departures of chief manufacturing officer Arno Groll and chief marketing officer Nick Davies, the company said in a release.

Shares of Hexo slipped as much as seven per cent to $3.26 on the Toronto Stock Exchange from its previous close of $3.51. The stock closed down 5.7 per cent at $3.31.

The cost-cutting measures came one day after Hexo postponed the release of its fourth-quarter results to Oct. 28 and its conference call to Oct. 29 as it announced a $70-million private placement of convertible debentures led by a group of investors, including St-Louis and board directors.

The company said that it intends to use the proceeds of the private placement for working capital and general corporate purposes.

Analysts said Wednesday that the involvement of senior management and directors in the financing as positive and said it would provide confidence to investors, but given that the conversion price of $3.16 was below the previous day’s close it also signals that Hexo has little conviction in its near-term outlook.

Story continues below advertisement

Earlier this month, Hexo said its fourth quarter net revenue was expected to be about $14.5 million to $16.5 million, down from the roughly $26 million it had forecast previously. Hexo also said it was withdrawing its previously issued outlook for its 2020 financial year of up to $400 million in net revenue.

The executive departures announced Thursday are the latest changes in the upper ranks of the cannabis company.

Also in early October, Hexo said its chief financial officer Michael Monahan resigned, effective immediately, after taking on the role in May, citing family reasons.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies